CDXS Codexis Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CDXS

Price (delayed)

$11.44

Market cap

$747.08M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.33

Enterprise value

$698.01M

Highlights
CDXS's revenue has surged by 69% year-on-year and by 17% since the previous quarter
Codexis's gross profit has surged by 68% YoY and by 16% QoQ
The debt has soared by 94% YoY
CDXS's quick ratio is down by 40% year-on-year and by 2.6% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://www.cedexis.com/
Peers: BCPC MRK PFE DD

Key stats

What are the main financial stats of CDXS
Market
Shares outstanding
65.3M
Market cap
$747.08M
Enterprise value
$698.01M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.7
Price to sales (P/S)
6.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.72
Earnings
Revenue
$122.06M
EBIT
-$20.37M
EBITDA
-$13.32M
Free cash flow
-$35.35M
Per share
EPS
-$0.33
Free cash flow per share
-$0.54
Book value per share
$2.43
Revenue per share
$1.88
TBVPS
$3.56
Balance sheet
Total assets
$235.27M
Total liabilities
$76.64M
Debt
$47.28M
Equity
$158.64M
Working capital
$115.37M
Liquidity
Debt to equity
0.3
Current ratio
4.91
Quick ratio
4.43
Net debt/EBITDA
3.68
Margins
EBITDA margin
-10.9%
Gross margin
78.3%
Net margin
-16.8%
Operating margin
-18%
Efficiency
Return on assets
-8.9%
Return on equity
-12.6%
Return on invested capital
-17.7%
Return on capital employed
-9.9%
Return on sales
-16.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDXS stock price

How has the Codexis stock price performed over time
Intraday
9.68%
1 week
26.41%
1 month
16.14%
1 year
-48.77%
YTD
-63.42%
QTD
-44.52%

Financial performance

How have Codexis's revenue and profit performed over time
Revenue
$122.06M
Gross profit
$95.55M
Operating income
-$21.93M
Net income
-$20.57M
Gross margin
78.3%
Net margin
-16.8%
CDXS's revenue has surged by 69% year-on-year and by 17% since the previous quarter
Codexis's gross profit has surged by 68% YoY and by 16% QoQ
The net margin has soared by 52% YoY and by 17% from the previous quarter
The operating margin rose by 48% year-on-year and by 17% since the previous quarter

Growth

What is Codexis's growth rate over time

Valuation

What is Codexis stock price valuation
P/E
N/A
P/B
4.7
P/S
6.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.72
The EPS is up by 20% year-on-year
CDXS's price to book (P/B) is 62% lower than its 5-year quarterly average of 12.4 and 52% lower than its last 4 quarters average of 9.7
The equity has declined by 3.5% since the previous quarter and by 3.1% year-on-year
CDXS's revenue has surged by 69% year-on-year and by 17% since the previous quarter
The price to sales (P/S) is 61% lower than the last 4 quarters average of 15.7 and 54% lower than the 5-year quarterly average of 13.2

Efficiency

How efficient is Codexis business performance
The return on sales has surged by 52% year-on-year and by 17% since the previous quarter
The company's return on invested capital has surged by 52% YoY and by 21% QoQ
Codexis's return on assets has increased by 38% YoY and by 6% QoQ
Codexis's return on equity has increased by 36% YoY and by 2.3% QoQ

Dividends

What is CDXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDXS.

Financial health

How did Codexis financials performed over time
The total liabilities has surged by 58% year-on-year but it has declined by 7% since the previous quarter
CDXS's quick ratio is down by 40% year-on-year and by 2.6% since the previous quarter
The debt is 70% less than the equity
The company's debt to equity has surged by 100% YoY and by 3.4% QoQ
The debt has soared by 94% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.